Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis.

Phillips HM, Stothard CA, Shaikh Qureshi WM, Kousa AI, Briones-Leon JA, Khasawneh RR, O'Loughlin C, Sanders R, Mazzotta S, Dodds R, Seidel K, Bates T, Nakatomi M, Cockell SJ, Schneider JE, Mohun TJ, Maehr R, Kist R, Peters H, Bamforth SD.

Development. 2019 Sep 23;146(18). pii: dev177618. doi: 10.1242/dev.177618.

2.

Increased Incidence of Central Venous Catheter-Related Infection in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.

Waters PS, Smith AW, Fitzgerald E, Khan F, Moran BJ, Shields CJ, Lynch BL, O'Loughlin C, Lynch M, Mulsow J.

Surg Infect (Larchmt). 2019 Sep;20(6):465-471. doi: 10.1089/sur.2018.250. Epub 2019 Apr 23.

PMID:
31013189
3.

Intensive Care Society of Ireland - Guidelines for management of the potential organ donor (2018-2nd edition).

Conrick-Martin I, Gaffney A, Dwyer R, O'Loughlin C, Colreavy F; Intensive Care Society of Ireland.

Ir J Med Sci. 2019 Nov;188(4):1111-1118. doi: 10.1007/s11845-019-01987-9. Epub 2019 Mar 5. No abstract available.

PMID:
30834487
4.

C. elegans avoids toxin-producing Streptomyces using a seven transmembrane domain chemosensory receptor.

Tran A, Tang A, O'Loughlin CT, Balistreri A, Chang E, Coto Villa D, Li J, Varshney A, Jimenez V, Pyle J, Tsujimoto B, Wellbrook C, Vargas C, Duong A, Ali N, Matthews SY, Levinson S, Woldemariam S, Khuri S, Bremer M, Eggers DK, L'Etoile N, Miller Conrad LC, VanHoven MK.

Elife. 2017 Sep 5;6. pii: e23770. doi: 10.7554/eLife.23770.

5.

The implementation of the Vessel Health and Preservation framework.

Weston V, Nightingale A, O'Loughlin C, Ventura R.

Br J Nurs. 2017 Apr 27;26(8):S18-S22. doi: 10.12968/bjon.2017.26.8.S18.

PMID:
28453315
6.

Multiple intra-hospital transports during relocation to a new critical care unit.

O'Leary RA, Conrick-Martin I, O'Loughlin C, Curran MR, Marsh B.

Ir J Med Sci. 2017 Nov;186(4):815-820. doi: 10.1007/s11845-016-1528-1. Epub 2016 Nov 7.

PMID:
27822907
7.

Clinical evaluation of a securement device used on midline catheters.

Ventura R, O'Loughlin C, Vavrik B.

Br J Nurs. 2016 Jul 28;25(14):S16-22. doi: 10.12968/bjon.2016.25.14.S16.

PMID:
27467651
8.

First-generation antipsychotics: not gone but forgotten.

Dibben CR, Khandaker GM, Underwood BR, O'Loughlin C, Keep C, Mann L, Jones PB.

BJPsych Bull. 2016 Apr;40(2):93-6. doi: 10.1192/pb.bp.115.050708.

9.

Does the social context of early alcohol use affect risky drinking in adolescents? Prospective cohort study.

Degenhardt L, Romaniuk H, Coffey C, Hall WD, Swift W, Carlin JB, O'Loughlin C, Patton GC.

BMC Public Health. 2015 Nov 16;15:1137. doi: 10.1186/s12889-015-2443-5.

10.

Development of potent inhibitors of pyocyanin production in Pseudomonas aeruginosa.

Miller LC, O'Loughlin CT, Zhang Z, Siryaporn A, Silpe JE, Bassler BL, Semmelhack MF.

J Med Chem. 2015 Feb 12;58(3):1298-306. doi: 10.1021/jm5015082. Epub 2015 Feb 3.

11.

Salinomycin and other polyether ionophores are a new class of antiscarring agent.

Woeller CF, O'Loughlin CW, Roztocil E, Feldon SE, Phipps RP.

J Biol Chem. 2015 Feb 6;290(6):3563-75. doi: 10.1074/jbc.M114.601872. Epub 2014 Dec 23.

12.

Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.

Woeller CF, O'Loughlin CW, Pollock SJ, Thatcher TH, Feldon SE, Phipps RP.

FASEB J. 2015 Mar;29(3):920-31. doi: 10.1096/fj.14-257121. Epub 2014 Nov 21.

13.

Social and emotional adjustment following early pregnancy in young Australian women: a comparison of those who terminate, miscarry, or complete pregnancy.

Olsson CA, Horwill E, Moore E, Eisenberg ME, Venn A, O'Loughlin C, Patton GC.

J Adolesc Health. 2014 Jun;54(6):698-703. doi: 10.1016/j.jadohealth.2013.10.203. Epub 2014 Jan 15.

PMID:
24438851
14.

A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation.

O'Loughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL.

Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17981-6. doi: 10.1073/pnas.1316981110. Epub 2013 Oct 18.

15.

Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.

Kuriyan AE, Woeller CF, O'Loughlin CW, Phipps RP, Feldon SE.

Invest Ophthalmol Vis Sci. 2013 Nov 8;54(12):7370-7. doi: 10.1167/iovs.13-12741.

16.

The persistence of adolescent binge drinking into adulthood: findings from a 15-year prospective cohort study.

Degenhardt L, O'Loughlin C, Swift W, Romaniuk H, Carlin J, Coffey C, Hall W, Patton G.

BMJ Open. 2013 Aug 19;3(8):e003015. doi: 10.1136/bmjopen-2013-003015.

17.

Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.

Abulhul E, McDonald K, Martos R, Phelan D, Spiers JP, Hennessy M, Baugh J, Watson C, O'Loughlin C, Ledwidge M.

Clin Ther. 2012 Jan;34(1):91-100. doi: 10.1016/j.clinthera.2011.11.002. Epub 2011 Dec 9.

PMID:
22154198
18.

Adolescent depressive symptoms and subsequent pregnancy, pregnancy completion and pregnancy termination in young adulthood: findings from the victorian adolescent health cohort study.

Nilsen W, Olsson CA, Karevold E, O'Loughlin C, McKenzie M, Patton GC.

J Pediatr Adolesc Gynecol. 2012 Feb;25(1):6-11. doi: 10.1016/j.jpag.2011.06.013. Epub 2011 Nov 16.

PMID:
22088312
19.

Frequency and use of pain assessment tools implemented in randomized controlled trials in the adult burns population: a systematic review.

Mahar PD, Wasiak J, O'Loughlin CJ, Christelis N, Arnold CA, Spinks AB, Danilla S.

Burns. 2012 Mar;38(2):147-54. doi: 10.1016/j.burns.2011.09.015. Epub 2011 Oct 26. Review.

PMID:
22032806
20.

A strategy for antagonizing quorum sensing.

Chen G, Swem LR, Swem DL, Stauff DL, O'Loughlin CT, Jeffrey PD, Bassler BL, Hughson FM.

Mol Cell. 2011 Apr 22;42(2):199-209. doi: 10.1016/j.molcel.2011.04.003.

21.

Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

Jan A, Murphy NF, O'Loughlin C, Ledwidge M, McDonald K.

Ir J Med Sci. 2011 Jun;180(2):355-62. doi: 10.1007/s11845-011-0689-1. Epub 2011 Mar 3.

PMID:
21369749
22.

B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.

Conlon CM, Dawkins I, O'Loughlin C, Gibson D, Kelleher CC, Ledwidge M, McDonald K.

Clin Chem Lab Med. 2011 Apr;49(4):719-28. doi: 10.1515/CCLM.2011.098. Epub 2011 Jan 31.

PMID:
21275814
23.

MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.

Girvan RC, Knight DA, O'Loughlin CJ, Hayman CM, Hermans IF, Webster GA.

Vaccine. 2011 Jan 10;29(3):545-57. doi: 10.1016/j.vaccine.2010.10.040. Epub 2010 Oct 27.

PMID:
21034827
24.

Novel anti-adipogenic activity produced by human fibroblasts.

Lehmann GM, Woeller CF, Pollock SJ, O'Loughlin CW, Gupta S, Feldon SE, Phipps RP.

Am J Physiol Cell Physiol. 2010 Sep;299(3):C672-81. doi: 10.1152/ajpcell.00451.2009. Epub 2010 Jun 16.

25.

Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease.

Guo N, Baglole CJ, O'Loughlin CW, Feldon SE, Phipps RP.

J Biol Chem. 2010 May 21;285(21):15794-804. doi: 10.1074/jbc.M109.074534. Epub 2010 Mar 22.

26.

Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Levesque MC, Hobbs MR, O'Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, Booth J, Patch KB, Allgood S, Pole AR, Fernandez CA, Mwaikambo ED, Mutabingwa TK, Fried M, Sorensen B, Duffy PE, Granger DL, Anstey NM, Weinberg JB.

Hum Genet. 2010 Feb;127(2):163-82. doi: 10.1007/s00439-009-0753-3. Epub 2009 Oct 27.

27.

Inappropriate use of proton pump inhibitors.

Molloy D, Molloy A, O'Loughlin C, Falconer M, Hennessy M.

Ir J Med Sci. 2010 Mar;179(1):73-5. doi: 10.1007/s11845-009-0426-1. Epub 2009 Sep 11.

PMID:
19763673
28.

A quorum-sensing antagonist targets both membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity.

Swem LR, Swem DL, O'Loughlin CT, Gatmaitan R, Zhao B, Ulrich SM, Bassler BL.

Mol Cell. 2009 Jul 31;35(2):143-53. doi: 10.1016/j.molcel.2009.05.029.

29.

Can we reduce preventable heart failure readmissions in patients enrolled in a Disease Management Programme?

Phelan D, Smyth L, Ryder M, Murphy N, O'Loughlin C, Conlon C, Ledwidge M, McDonald K.

Ir J Med Sci. 2009 Jun;178(2):167-71. doi: 10.1007/s11845-009-0332-6. Epub 2009 May 1.

PMID:
19408042
30.

STAR*D: a summary and UK perspective.

Deakin J, O'Loughlin C.

J Psychopharmacol. 2009 Aug;23(6):605-12. doi: 10.1177/0269881109104886. Epub 2009 Apr 24. Review. No abstract available.

PMID:
19395428
31.

The value of level III clearance in patients with axillary and sentinel node positive breast cancer.

Dillon MF, Advani V, Masterson C, O'Loughlin C, Quinn CM, O'Higgins N, Evoy D, McDermott EW.

Ann Surg. 2009 May;249(5):834-9. doi: 10.1097/SLA.0b013e3181a40821.

PMID:
19387317
32.

Causes and consequences of nonpersistence with heart failure medication.

Mockler M, O'Loughlin C, Murphy N, Ryder M, Conlon C, McDonald KM, Ledwidge MT.

Am J Cardiol. 2009 Mar 15;103(6):834-8. doi: 10.1016/j.amjcard.2008.11.058.

PMID:
19268741
33.

A comparative study of the palliative care needs of heart failure and cancer patients.

O'Leary N, Murphy NF, O'Loughlin C, Tiernan E, McDonald K.

Eur J Heart Fail. 2009 Apr;11(4):406-12. doi: 10.1093/eurjhf/hfp007. Epub 2009 Feb 5.

34.

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

Martos R, Baugh J, Ledwidge M, O'Loughlin C, Murphy NF, Conlon C, Patle A, Donnelly SC, McDonald K.

Eur J Heart Fail. 2009 Feb;11(2):191-7. doi: 10.1093/eurjhf/hfn036.

35.

Sources and acceptance of infant-feeding advice among low-income women.

Heinig MJ, Ishii KD, Bañuelos JL, Campbell E, O'Loughlin C, Vera Becerra LE.

J Hum Lact. 2009 May;25(2):163-72. doi: 10.1177/0890334408329438. Epub 2009 Jan 8.

PMID:
19136396
36.

Quality of life predicts outcome in a heart failure disease management program.

O'Loughlin C, Murphy NF, Conlon C, O'Donovan A, Ledwidge M, McDonald K.

Int J Cardiol. 2010 Feb 18;139(1):60-7. doi: 10.1016/j.ijcard.2008.09.003. Epub 2008 Oct 12.

PMID:
18851887
37.

Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?

Mak G, Murphy NF, Ali A, Walsh A, O'Loughlin C, Conlon C, McCaffrey D, Ledwidge M, McDonald K.

J Card Fail. 2008 Sep;14(7):555-60. doi: 10.1016/j.cardfail.2008.03.003. Epub 2008 May 27.

PMID:
18722320
38.

Intramammary infusion of a live culture for treatment of bovine mastitis: effect of live lactococci on the mammary immune response.

Crispie F, Alonso-Gómez M, O'Loughlin C, Klostermann K, Flynn J, Arkins S, Meaney W, Paul Ross R, Hill C.

J Dairy Res. 2008 Aug;75(3):374-84. doi: 10.1017/S0022029908003385.

PMID:
18680623
39.

Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.

Kuriyan AE, Phipps RP, O'Loughlin CW, Feldon SE.

Thyroid. 2008 Aug;18(8):911-4. doi: 10.1089/thy.2007.0325. No abstract available.

40.

Diagnosis of new onset heart failure in the community: the importance of a shared-care approach and judicious use of BNP.

Mak G, Ryder M, Murphy NF, O'Loughlin C, McCaffrey D, Ledwidge M, McDonald K.

Ir J Med Sci. 2008 Sep;177(3):197-203. doi: 10.1007/s11845-008-0186-3. Epub 2008 Jul 17.

PMID:
18633669
41.

Sub-optimal pain control in patients with rheumatic disease.

Sheane BJ, Doyle F, Doyle C, O'Loughlin C, Howard D, Cunnane G.

Clin Rheumatol. 2008 Aug;27(8):1029-33. doi: 10.1007/s10067-008-0881-5. Epub 2008 May 29.

PMID:
18509716
42.

Need and evolution of need for device therapy in a community heart failure population.

Sulaiman HM, O'Loughlin C, Daly M, Conlon C, Ledwidge M, McCaffrey D, McDonald K.

Eur J Heart Fail. 2008 Jun;10(6):601-7. doi: 10.1016/j.ejheart.2008.04.010. Epub 2008 May 21.

43.

Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure.

Ryder M, Murphy NF, McCaffrey D, O'Loughlin C, Ledwidge M, McDonald K.

Eur J Heart Fail. 2008 Mar;10(3):267-72. doi: 10.1016/j.ejheart.2008.01.003. Epub 2008 Mar 4.

44.

CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant.

Levesque MC, Ghosh DK, Beasley BE, Chen Y, Volkheimer AD, O'Loughlin CW, Gockerman JP, Moore JO, Weinberg JB.

Leuk Res. 2008 Jul;32(7):1061-70. doi: 10.1016/j.leukres.2007.11.026. Epub 2008 Jan 3.

PMID:
18180035
45.

Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.

Murphy NF, O'Loughlin C, Ledwidge M, McCaffrey D, McDonald K.

Eur J Heart Fail. 2007 Dec;9(12):1196-204.

46.

Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant.

Kelly CD, O'Loughlin C, Gelder FB, Peterson JW, Sower LE, Cirino NM.

J Immune Based Ther Vaccines. 2007 Oct 22;5:11.

47.

Designing multidisciplinary longitudinal studies of human development: analyzing past research to inform methodology.

Shulruf B, Morton S, Goodyear-Smith F, O'Loughlin C, Dixon R.

Eval Health Prof. 2007 Sep;30(3):207-28. Review.

PMID:
17693616
48.

Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability.

Travers B, O'Loughlin C, Murphy NF, Ryder M, Conlon C, Ledwidge M, McDonald K.

J Card Fail. 2007 Mar;13(2):128-32.

PMID:
17395053
49.

The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.

O'Hanlon R, O'Shea P, Ledwidge M, O'Loughlin C, Lange S, Conlon C, Phelan D, Cunningham S, McDonald K.

J Card Fail. 2007 Feb;13(1):50-5. Review. Erratum in: J Card Fail. 2007 Mar;13(2):163.

PMID:
17339003
50.

Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: a marker of diastolic dysfunction and clinical risk.

Karuppiah S, Graham F, Ledwidge M, Conlon C, Cahill J, O'Loughlin C, McManus J, McDonald K.

Ir J Med Sci. 2006 Oct-Dec;175(4):5-13.

PMID:
17312822

Supplemental Content

Loading ...
Support Center